Strober, Bruce, Alice Gottlieb, Diamant Tha?i, Luis Puig, Matthew J Colombo, Sundeep Kundu, Renata Kisa, and Subhashis Banerjee. “An Oral, Selective Tyrosine Kinase 2 Inhibitor, BMS-986165, Reduced Absolute Psoriasis Area and Severity Index in a Phase 2 Trial in Psoriasis”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s27. Accessed June 30, 2022. https://www.jofskin.org/index.php/skin/article/view/976.